Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Familial prevalence and age of RET germline mutations: implications for screening.

Clinical endocrinology - 1 Jul 2008

Machens Andreas, Dralle Henning

Abstract excerpt

OBJECTIVE: No comprehensive information exists nationwide about the familial prevalence and age of rearranged during transfection (RET) germline mutations. The current investigation was undertaken to provide such natural history data which are urgently needed to enable factual decision-making abo...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Evolution, Molecular
Share to Family
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germ-Line Mutation

Share to Heterozygote

Share to Multiple Endocrine Neoplasia Type 2a

Share to Proto-Oncogene Proteins c-ret

Share to Time Factors

Source

Identifiers

PMID: 18062802
DOI: 10.1111/j.1365-2265.2007.03153.x

Genes

RET

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18062802-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Familial prevalence and age of RET germline mutations: implications for screening.PMID 18062802Read ↗

Distribution of RET Mutations in Multiple Endocrine Neoplasia 2 in Denmark 1994–2014: A Nationwide StudySemantic proximity Read ↗

De novo mutation of the RET proto-oncogene revealing multiple endocrine neoplasia type 2A: a sporadic case from Western Algeria.Semantic proximity Read ↗

Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET MutationsSemantic proximity Read ↗

Molecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new millenium.Semantic proximity Read ↗

Founder Effect of the RETC611Y Mutation in Multiple Endocrine Neoplasia 2A in Denmark: A Nationwide Study.Semantic proximity Read ↗

Geospatial inheritance across the breath of the RET mutational landscape of multiple endocrine neoplasia 2A.Semantic proximity Read ↗

RET 634 germline/gonadal mosaicism generating a second pathogenic amino acid change in multiple endocrine neoplasia type 2A.Semantic proximity Read ↗

Nationwide French Study of RET Variants Detected from 2003 to 2013 Suggests a Possible Influence of Polymorphisms as Modifiers.Semantic proximity Read ↗

Accelerated MEN2A in homozygous RET carriers in the context of consanguinity.Semantic proximity Read ↗

The clinical spectrum of multiple endocrine neoplasia type 2a caused by the rare intracellular RET mutation S891A.Semantic proximity Read ↗

Impact of RET proto-oncogene analysis on the clinical management of multiple endocrine neoplasia type 2.Semantic proximity Read ↗

GLOBAL ENDOCRINOLOGY: Geographical variation in the profile of RET variants in patients with medullary thyroid cancer: a comprehensive review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.